FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder
http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-eosinophilic-esophagitis-chronic-immune-disorder

FDA Roundup: May 20, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-20-2022

FDA Urges Drug Manufacturers to Develop Risk Management Plans to Promote a Stronger, Resilient Drug Supply Chain
http://www.fda.gov/news-events/press-announcements/fda-urges-drug-manufacturers-develop-risk-management-plans-promote-stronger-resilient-drug-supply

New FDA Draft Guidance Aims to Increase Safety Information About Dietary Supplement Marketplace
http://www.fda.gov/news-events/press-announcements/new-fda-draft-guidance-aims-increase-safety-information-about-dietary-supplement-marketplace

http://www.fda.gov/vaccines-blood-biologics/recalls-biologics/urgent-voluntary-recall-corneagen-sclera-scleral-patch-grafts-corneagen-voluntarily-recalling-entire

http://www.fda.gov/medical-devices/safety-communications/update-certain-philips-respironics-ventilators-bipap-machines-and-cpap-machines-recalled-due

http://www.fda.gov/medical-devices/safety-communications/faqs-philips-respironics-ventilator-bipap-machine-and-cpap-machine-recalls

http://www.fda.gov/vaccines-blood-biologics/recalls-biologics/2022-biologics-recalls

Regulación internacional sobre la edad para el uso de la segunda dosis de refuerzo de la vacuna contra el SARS-CoV-2
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1369299

FDA Roundup: May 17, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-17-2022